A NovoCare® Recognized Care Provider, Weight Watchers’ new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication aloneNEW YORK, Jan. 05, 2026 ...

WW International stock currently trades at $7.30 per share, 82% below its pre-inflation shock high of $41, seen in December 2021, and has the potential for meaningful gains. WW saw its stock trading ...

WW International press release (NASDAQ:WW): Q4 EPS of -$1.11 may not be comparable to consensus of -$0.09. Revenue of $206M (-7.6% Y/Y) misses by $0.91M. End of Period Subscribers of 3.8 million, ...

WW International stock has fallen by close to 8% over the last month and remains down by 77% year-to-date. It has been a perfect storm of sorts for the stock. The big health and fitness focus seen ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

One stock that has been struggling out of the gate in 2024 is WW International (NASDAQ: WW), better known as WeightWatchers. Already down more than 50% this year, it has been in a rapid free fall and ...

The company signed a distribution deal with a big name in e-commerce. That partner will help ship its weight-management medications. Before market open that day, WW International announced it has ...

Powerful healthcare company Eli Lilly introduced a new e-commerce platform that will surely boost sales of its new weight loss drug. Investors fear this will put a real dent in WW International's ...

For a company to consistently earn economic profits, competitive advantages are necessary. WW will acquire Sequence, a telehealth platform focused on GLP-1 medications, and I doubt this deal will help ...

WW International (NASDAQ: WW) dropped by close to 25% in Wednesday’s trading, after the company published a weaker than expected set of Q2 2021 earnings and provided a tough outlook for the rest of ...

WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced access to Novo Nordisk's newly ...